The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Kwells 300 microgram Tablets

Dexcel Pharma GmbHPA2261/006/001

Main Information

Trade NameKwells 300 microgram Tablets
Active SubstancesHyoscine hydrobromide
Dosage FormTablet
Licence HolderDexcel Pharma GmbH
Licence NumberPA2261/006/001

Group Information

ATC CodeA04AD Other antiemetics
A04AD01 scopolamine


Licence Issued01/04/1979
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back